Madrigal Pharmaceuticals, Inc. MDGL Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s other operating expenses?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported other operating expenses of $404.06M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s other operating expenses increased by 86.6% year-over-year, from $216.56M to $404.06M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s other operating expenses has grown at a 50.9% compound annual growth rate (CAGR), from $242.48M to $1.26B.